mutLBSgeneDB |
Gene summary for GGA1 |
![]() |
Basic gene Info. | Gene symbol | GGA1 |
Gene name | golgi-associated, gamma adaptin ear containing, ARF binding protein 1 | |
Synonyms | - | |
Cytomap | UCSC genome browser: 22q13.31 | |
Type of gene | protein-coding | |
RefGenes | NM_001001560.2, NM_001172687.1,NM_001172688.1,NM_013365.4,NM_001001561.2, | |
Description | ADP-ribosylation factor binding protein 1ADP-ribosylation factor-binding protein GGA1gamma-adaptin related protein 1gamma-adaptin-related protein 1golgi associated, gamma adaptin ear containing, ARF binding protein 1golgi-localized, gamma ear-contain | |
Modification date | 20141207 | |
dbXrefs | MIM : 606004 | |
HGNC : HGNC | ||
Ensembl : ENSG00000100083 | ||
HPRD : 12078 | ||
Vega : OTTHUMG00000030985 | ||
Protein | UniProt: Q9UJY5 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_GGA1 | |
BioGPS: 26088 | ||
Pathway | NCI Pathway Interaction Database: GGA1 | |
KEGG: GGA1 | ||
REACTOME: GGA1 | ||
Pathway Commons: GGA1 | ||
Context | iHOP: GGA1 | |
ligand binding site mutation search in PubMed: GGA1 | ||
UCL Cancer Institute: GGA1 | ||
Assigned class in mutLBSgeneDB | C: This gene just belongs to mutLBSgenes. |
![]() |
GO ID | GO Term | PubMed ID |
Top |
Ligand binding site mutations for GGA1 |
![]() We represented ligand binding site mutations only. (You can see big image via clicking.) ![]() |
![]() |
![]() |
LBS | AAchange of nsSNV | Cancer type | # samples | K131 | I132M | HNSC | 1 | R89 | R89C | LAML | 1 |
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
Top |
Protein structure related information for GGA1 |
![]() Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
![]() ![]() |
![]() |
![]() Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
LBS | AAchange of nsSNV | Relative stability change | R89 | R89C | -0.72993807 | K131 | I132M | -0.54852478 |
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
![]() |
Top |
Differential gene expression and gene-gene network for GGA1 |
![]() |
![]() |
Top |
Top |
Phenotype information for GGA1 |
![]() |
Disease ID | Disease name | # PubMed | Association type |
![]() |
Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
Top |
Pharmacological information for GGA1 |
![]() Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
![]() |
![]() |
Drug status | DrugBank ID | Name | Type | Drug structure |
![]() |
![]() |
![]() |
Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS | III | Peptide ligand (ASP,GLU,ASP,LEU,LEU,HIS,ILE) | 1jwg | A | R89 K131 | III | Peptide ligand (ASP,ASP,ILE,SER,LEU,LEU,LYS) | 1py1 | A | R89 K131 | III | Peptide ligand (ASP,ASP,ILE,SER,LEU,LEU,LYS) | 1py1 | B | R89 K131 | III | Peptide ligand (ASP,ILE,SER,LEU,LEU,LYS) | 1py1 | C | R89 K131 | III | Peptide ligand (ASP,ASP,ILE,SER,LEU,LEU,LYS) | 1py1 | D | R89 K131 | III | Peptide ligand (ASP,ASP,ILE,SER,LEU,LEU,LYS) | 1ujj | A | R89 K131 | III | Peptide ligand (ASP,ASP,ILE,SER,LEU,LEU,LYS) | 1ujk | A | R89 K131 | III | Peptide ligand (ASP,ASP,ILE,SER,LEU,LEU,LYS) | 1ujk | B | R89 K131 | III | Peptide ligand (GLY,PHE,SER,ASP,ASP,VAL,PRO,MET,VAL,ILE,ALA) | 3g2s | A | R89 K131 | III | Peptide ligand (GLY,PHE,SER,ASP,ASP,VAL,PRO,MET,VAL,ILE,ALA) | 3g2s | B | R89 K131 | III | Peptide ligand (SER,ASP,ASP,VAL,PRO,MET,VAL,ILE,ALA) | 3g2t | A | R89 K131 | III | Peptide ligand (SER,ASP,ASP,VAL,PRO,MET,VAL,ILE,ALA) | 3g2t | B | R89 K131 | III | Peptide ligand (SER,ASP,GLU,ASP,LEU,LEU,GLU) | 3g2u | A | R89 K131 | III | Peptide ligand (SER,ASP,GLU,ASP,LEU,LEU,GLU) | 3g2u | B | R89 K131 | III | Peptide ligand (ASP,ASP,SER,ASP,GLU,ASP,LEU,LEU,GLU) | 3g2v | A | R89 K131 | III | Peptide ligand (SER,ASP,GLU,ASP,LEU,LEU,GLU) | 3g2v | B | R89 K131 | III | Peptide ligand (LEU,LEU,ASP,ASP,GLU,LEU,MET,SER,LEU) | 3g2w | A | R89 K131 | III | Peptide ligand (LEU,LEU,ASP,ASP,GLU,LEU,MET,SER) | 3g2w | B | R89 K131 |
Top |
Conservation information for LBS of GGA1 |
![]() |
LBS | AA sequence | # species | Species |
![]() |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |